Venera Emruli

Senior Scientist Strike Pharma

Seminars

Thursday 26th February 2026
Advancing In-Vivo CAR-T Therapies through Adaptable Lipid Nanoparticle Delivery
4:00 pm
  • Explore a novel platform enabling adaptable lipid nanoparticle (LNP) delivery for in-vivo CAR-T applications
  • Discuss how merging antibody and LNP technologies enhances targeting precision and delivery efficiency

New Data

Venera Emruli